Amy Pace, ScD

Amy is Vice President of Biostatistics at Parexel. She is responsible for providing statistical consultation on clinical development programs, including clinical development plans, protocols, statistical analysis plans, clinical study reports, regulatory submission materials, reimbursement dossiers, and publications.

Work Experience

Amy has more than 20 years of drug development experience in the biotech/pharmaceutical industry. Her expertise encompasses optimizing trial design, deep knowledge of various statistical models and applications, and a thorough understanding of the regulatory environment, including direct interactions with global health authorities. She has extensive experience in Phase I–IV drug development in the industry, including tenures with Biogen and Alexion and in major markets including North America, the EU, and Japan.

Education

Amy holds a Doctor of Science degree in Biostatistics from the Harvard T.H. Chan School of Public Health. She is based in Boston, MA.